Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (251-260 of 384) with videos related to

Pageof 39
Sort By:
International Angiology : a Journal of the International Union of Angiology|December 11, 2012
Thromboelastographic evaluation of blood coagulation in the presence of branded and generic enoxaparinsJ M Walenga, W P Jeske, V Escalante, et al.
Haemostasis|January 1, 1991
Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis modelC Doutremepuich, M C Lalanne, F Doutremepuich, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2003
Influence of different anticoagulant agents on fibrinopeptide a generationM Tobu, O Iqbal, H L Messmore, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1982
Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurementsJ Fareed, H L Messmore, J M Walenga, et al.
Clinical Cardiology|July 1, 1996
Coagulation and fibrinolytic parameters in patients with pulmonary hypertensionR Altman, A Scazziota, J Rouvier, et al.
The Journal of Trauma|May 1, 1996
Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary resultsD G Jacobs, J J Piotrowski, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycanM T Nurmohamed, J Fareed, D Hoppensteadt, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparinZ Shriver, M Sundaram, G Venkataraman, et al.
Thrombosis Research|October 29, 2000
Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primatesS Ahmad, W P Jeske, J M Walenga, et al.
Thrombosis Research|July 4, 2001
Heparin and a cyclic octaphenol-octasulfonic acid (GL-522-Y-1) bind with high affinity to a 47-kda protein from vascular endothelial cell surface and stimulate the synthesis and structural changes of heparan sulfate proteoglycanM A Pinhal, E S Trindade, J Fareed, et al.
Pageof 39

Showing results (251-260 of 384) with videos related to

Sort By:
Pageof 39
International Angiology : a Journal of the International Union of Angiology|December 11, 2012
Thromboelastographic evaluation of blood coagulation in the presence of branded and generic enoxaparinsJ M Walenga, W P Jeske, V Escalante, et al.
Haemostasis|January 1, 1991
Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis modelC Doutremepuich, M C Lalanne, F Doutremepuich, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 5, 2003
Influence of different anticoagulant agents on fibrinopeptide a generationM Tobu, O Iqbal, H L Messmore, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1982
Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurementsJ Fareed, H L Messmore, J M Walenga, et al.
Clinical Cardiology|July 1, 1996
Coagulation and fibrinolytic parameters in patients with pulmonary hypertensionR Altman, A Scazziota, J Rouvier, et al.
The Journal of Trauma|May 1, 1996
Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary resultsD G Jacobs, J J Piotrowski, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycanM T Nurmohamed, J Fareed, D Hoppensteadt, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparinZ Shriver, M Sundaram, G Venkataraman, et al.
Thrombosis Research|October 29, 2000
Human anti-heparin-platelet factor 4 antibodies are capable of activating primate platelets: towards the development of a HIT model in primatesS Ahmad, W P Jeske, J M Walenga, et al.
Thrombosis Research|July 4, 2001
Heparin and a cyclic octaphenol-octasulfonic acid (GL-522-Y-1) bind with high affinity to a 47-kda protein from vascular endothelial cell surface and stimulate the synthesis and structural changes of heparan sulfate proteoglycanM A Pinhal, E S Trindade, J Fareed, et al.
Pageof 39